e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: A report of two cases

Journal of Clinical Pathology

Volumn 59, Issue 10, 2006, Pages 1102-1103

  Mondal, B C ^a   Majumdar, S ^a   Dasgupta, U B ^a   Chaudhuri, U ^b   Chakrabarti, P ^b   Bhattacharyya, S ^b  

^a UNIVERSITY OF CALCUTTA   (India)

^b Institute of Haematology and Transfusion Medicine   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; HYDROXYUREA; IMATINIB; PROTEIN E19A2; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; DISEASE PROGRESSION; FATAL OUTCOME; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, CHRONIC; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 33750020051     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.029595     Document Type: Article

References (9)

1. Saglio G, Guerraslo A, Rosso C, et al. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1990;76:1819-24.
2. Pane F, Frigeri F, Sindona M, et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996;88:2410-14.
3. Mittre H, Leymarie P, Macro M, et al. A new case of chronic myeloid leukemia with c3/a2 BCR/ABL junction. Is it really a distinct disease? Blood 1997;89:4239-41.
4. Bernasconi P, Calatroni S, Boni M, et al. p230 does not always predict a mild clinical course in myeloid malignancies: e19a2 bcr/abl fusion transcript with additional chromosome abnormalities in a patient with acute monoblastic leukemia (M5a). Haematologica 2001;86:320-1.
5. Haskovec C, Ponzetto C, Polak J, et al. P230 BCR/ABL protein may be associated with an acute leukaemia phenotype. Br J Haematol 1998;103:1104-8.
6. Martinez-Lopez J, Ayala R, Albizua Q. Typical chronic myelogenous leukemia with e19a2 BCR/ABL transcript. Report of two cases. Haematologica 2002;87:ELT35.
7. Li S, Ilaria RL Jr, Million RP, et al. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 1999;189:1399-412.
8. Inokuchi K, Dan K, Takatori M, et al. Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis. Blood 2003;102:320-3.
9. Quackanbush RC, Reuther GW, Miller JP, et al. Analysis of the biologic properties of P230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases. Blood 2000;95:2913-21.